Research article · 11 Jun 2026
Conference abstractPublished 2015
Regulation of miR-34a-SIRT1 axis reduced breast cancer stemness
Dalian University of Technology, China Dalian Medical University, China Creighton University Medical Center, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: Recent studies showed that enforced expression of miR-34a resulted in elimination of cancer stem cells in many tumors, including prostate, pancreatic cancers. In this study, we aim to understand regulatory mechanism of miR-34a in breast cancer stemcells (BCSCs). Methods: CD44+/CD24− breast cancer stem cells (BCSCs) were isolated from MCF-7 cell line. Total RNA and protein was extracted from BCSCs and xenograft tissues. Levels of miR-34a, Sirtuin1 (SIRT1), ALDH1, BMI1 and Nanog, were measured by using q RT-PCR and Western blot. Cell proliferation and differentiation were measured by assays of CCK-8, colony formation and mammosphere formation. Cell apoptosis was measured by flow cytometry. Four groups of mice (n=5), lentivirus-hsa-miR-34a, shRNA-SIRT1, lentivirus-hsa-NC, and shRNA-Control, were used for study on tumor formation and growth. Results: Lower endogenous level of miR-34a and higher level of Sirtuin1 (SIRT1) gene in CD44+/CD24- BCSCs than in breast cancer cells was identified. Further study demonstrated that miR-34a directly targeted SIRT1 gene leading to reduced SIRT1expression in the BCSCs. Either ectopic expression of miR-34a or silenced SIRT1 inMCF-7 cells inhibited cellular proliferation, and led to cell apoptosis. Over expression of miR-34a also suppressed expression of ALDH1, BMI1 and Nanog, and decreasedcapacity of mammosphere formation of the BCSCs significantly, suggesting thereduced stemness of BCSCs. Studies in vivo showed that stable expression of miR-34a reduced tumor burden significantly in nude mice xenografts. Conclusion: Our results showed that anti-synergetic regulation of miR-34a-SIRT1 axis affected proliferation, colony formation, and mammosphere formation in BCSCs, suggesting that miR-34a-SIRT1 axis may play an important role in self-renewal and stemness maintenance of BCSCs. This study may provide a novel BCSCs specific therapeutic strategy to improve breast cancer treatments.
Subjects
EngineeringAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Regenerative Medicine.
Research article · 8 Aug 2025
Human Umbilical Cord-Derived Mesenchymal Stem Cells in Combination with Small Extracellular Vesicles Prevent the Development of Fibrosis and Cirrhosis and Improve Survival in Wistar Rats Receiving CCl₄
Opinion · 20 Feb 2025
CAR-T Cell Therapy: Expanding Applications beyond Hematologic Malignancies
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Regenerative Medicine
- SubjectEngineering
- BylineArticles whose byline prints “Gary Guishan Xiao”
- BylineArticles whose byline prints “Wei Ma”
- BylineArticles whose byline prints “Jun Mao”
- BylineArticles whose byline prints “Ying Lu”
- BylineArticles whose byline prints “Bo Song”
- BylineArticles whose byline prints “Wenyue Zhao”
- BylineArticles whose byline prints “Jiarui Zou”
- BylineArticles whose byline prints “Panhong Fan”
